Human BMP-4 / BMP2B (improved sequence) Protein, premium grade

  • GMP version GMP-BM4H18 is now available for seamless transition.
Customer Reviews
Cat. No. / Size
Price
Qty
Premium grade lyophilized
BM4-H5118-20ug
$335.00
BM4-H5118-50ug
$425.00
BM4-H5118-1mg (100ug X 10)
$3850.00
GMP lyophilized
GMP-BM4H18-50ug
$870.00
GMP-BM4H18-1mg (50ug X 20)
$8205.00
GMP-BM4H18-10mg (50ug X 200)
$57435.00
ETA of in-stock products:2 business days

Product Details

  • Features and Advantages

    1. Seamless Transition from Preclinical to Clinical: Same cell clone, process, and QC as GMP products.
    2. Enhanced Production Standards: AOF raw materials, pharma-grade excipients, Grade B+A (ISO 5) environment.
    3. Comprehensive Quality Control: Additional strict testing for process impurities, sterility, and mycoplasma.
    4. Cost-Effective Solution: GMP-comparable quality at an economical price for early development.
    5. Risk Mitigation: Enhanced safety through rigorous impurity control and comprehensive testing.
  • Synonyms

    BMP4, BMP2B, BMP2B1, MCOPS6, OFC11, ZYME

  • Source

    Human BMP-4 (improved sequence) Protein, premium grade (BM4-H5118) is expressed from E. coli cells. It is a variant of BMP-4 to suit cell culture applications better.

    It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage.
    GMP-BM4H18 is the GMP version of this BM4-H5118. These two proteins display indistinguishable performance profiles, thereby ensuring a seamless transition for end users from early preclinical stage to later clinical phases.

  • Molecular Characterization

    This protein carries no "tag".

    The protein has a calculated MW of 13.2 kDa. The protein migrates as 13 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).

  • Endotoxin

    Less than 0.05 EU per μg by the LAL method / rFC method.

  • Host Cell Protein

    <0.5 ng/µg of protein tested by ELISA.

  • Host Cell DNA

    <0.02 ng/μg of protein tested by qPCR.

  • Sterility

    Negative

  • Mycoplasma

    Negative

  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 20 mM Citric acid, pH2.2 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 24 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process
  • Quality Description

    ACRO's Research-grade products are suitable for a wide range of cell culture applications, particularly for research use in academic institutions. These products are sterilized by filtration, followed by lyophilization where applicable. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. Biological activity is calibrated against WHO/NIBSC standards when available.
    ACRO's Premium-grade (Pre-GMP) products are characterized by their high quality and enhanced safety profiles, making them ideal for early-stage discovery and manufacturing processes in cell therapy companies. A key advantage is their seamless transition to corresponding GMP-grade versions. Biological activity is calibrated against WHO/NIBSC standards when available. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. In addition, rigorous testing is conducted to ensure the absence of mycoplasma, HCD, and HCP, thereby guaranteeing product safety.

Customers Also Viewed

Performance Data

  • SDS-PAGE

    BMP-4 SDS-PAGE

    Human BMP-4 (improved sequence) Protein, premium grade on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-CELL BASE

     BMP-4 CELL

    Human BMP-4 (improved sequence) Protein, premium grade (Cat. No. BM4-H5118) stimulates Human BMP (Luc) HEK293 Reporter Cell. The specific activity of Human BMP-4 (improved sequence) Protein, premium grade is > 1.90 x 10^3 U/mg (QC tested).

    Protocol
  • Application Data

     BMP-4 APPLICATION DATA

    Human BMP-4 (improved sequence) Protein, premium grade (Cat. No. BM4-H5118) could significantly induce iPSC derived HSPC differentiation, with high expression of CD34 and CD45 (HSPC markers) by flow cytometry analysis and the increase of viable numbers of CD34+ CD45+ cells by cell counting (Data is the average of 3 independent experiments, error bars ± SD). NC: H2O treatment (Routinely tested).

  •  BMP-4 APPLICATION DATA

    Human BMP-4 (improved sequence) Protein, premium grade (Cat. No. BM4-H5118) could significantly inhibit endoderm cell marker FOXA2 expression and promote mesoderm cell marker Brachyury expression from iPSC differentiation by FACS analysis. NC: CHIR99021; ACRO: CHIR99021+BMP4 treatment (30 ng/mL) (Routinely tested).

  •  BMP-4 APPLICATION DATA

    Human BMP-4 (improved sequence) Protein, premium grade (Cat. No. BM4-H5118) could significantly inhibit endoderm cell marker FOXA2 expression and promote mesoderm cell marker Brachyury expression from iPSC differentiation by immunofluorescence staining. NC: CHIR99021; ACRO: CHIR99021+BMP4 treatment (30 ng/mL) (Routinely tested).

  • Bioactivity-Stability

     BMP-4 STABILITY

    Cell-based assay demonstrates batch-to-batch consistency between Acro's GMP and PG BMP-4 (improved sequence).

Customer Reviews
Writing Reviews

Background

Bone Morphogenetic Protein 4 (BMP4) is a member of growth factor of the TGF-beta superfamily that plays essential roles in many developmental processes, including neurogenesis, vascular development, angiogenesis and osteogenesis. BMP-4 Initiates the canonical BMP signaling cascade by associating with type I receptor BMPR1A and type II receptor BMPR2. BMP-4 can acts in concert with PTHLH/PTHRP to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction.

Recent Advances

 
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background